CVE-2025-61940
Mirion Biodose\/Nmis ≤ 23.0
Raw vector
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:XSummary
CVE-2025-61940 is a high-severity Use of Client-Side Authentication (CWE-603) vulnerability in Mirion Biodose\/Nmis. Its CVSS base score is 8.7 (High).
Operationally, exploitation aligns with the MITRE ATT&CK technique Exploit Public-Facing Application (T1190); ranked at the 25th percentile by exploit likelihood (below the median); it is not currently listed in the CISA KEV catalog.
The strongest mitigations our analysis identified map to AC-3 (Access Enforcement) and IA-2 (Identification and Authentication (Organizational Users)) — see the control section below for these in your framework.
Deeper analysis AI-assisted summary
Synthesised by an AI model from the NVD description and linked references — a reading aid, not an authoritative source.
CVE-2025-61940 is a vulnerability in NMIS/BioDose versions V22.02 and previous, stemming from the use of a common SQL Server user account with unrestricted database access. While the client application enforces user access restrictions via password authentication, the underlying database connection always uses this privileged account, bypassing client-side controls. Classified as CWE-603, it carries a CVSS v3.1 base score of 8.3 (AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L).
A low-privileged user (PR:L) with network access (AV:N) can exploit this issue with low attack complexity and no user interaction. The attacker leverages the privileged database connection to achieve high confidentiality impact through unauthorized data access, high integrity impact via data modification, and low availability impact.
The CISA ICS medical advisory (ICSMA-25-336-01) references mitigation via the latest NMIS/BioDose version, which introduces an option for Windows user authentication to restrict database connections based on user privileges.
EU & UK References
- 🇪🇺 ENISA EUVD: EUVD-2025-200322
Vulnerability Data
NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database…
more
connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.
- CWE(s)
Related Threats
MITRE ATT&CK Enterprise Techniques
CVEs Like This One
Affected Assets
Mitigating Controls
Control response
—
—
—
V10.4.10V10.4.15V10.4.16V10.7.1
Mitigating Controls (NIST 800-53 r5) AI
Enforces access authorizations on the server, making client-side bypass ineffective.
Requires server-side identification and authentication of users before granting access.
Mitigating Controls (NIST CSF 2.0) AI
Derived directly from the weakness types (CWEs) cited in the NVD entry via our AI-authored CWE→CSF cross-walk (authority under review) — links open the control.
Server-enforced authentication directly prevents client-only checks from being bypassed.
Mitigating Controls (ISO/IEC 27001:2022 Annex A) AI
Derived directly from the weakness types (CWEs) cited in the NVD entry via our AI-authored CWE→ISO cross-walk (authority under review) — links open the control.
Requires server-side authentication mechanisms that directly prevent client-only checks.
Promotes secure architecture principles that reject client-only authentication designs.
Security testing can detect missing server-side authentication checks.
Defines application security requirements that include server-side authentication enforcement.
Secure coding standards discourage reliance on client-side authentication logic.
Enforces access restrictions that must be validated on the server, mitigating client-side bypass.